4/21
01:07 pm
orka
Oruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for Investors [Globe and Mail, The (Toronto, Canada)]
Low
Report
Oruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for Investors [Globe and Mail, The (Toronto, Canada)]
4/21
12:57 pm
orka
Oruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for Investors [Yahoo! Finance]
Low
Report
Oruka Insider Sells $463K in Stock as Shares Skyrocket 650%, but Here's What Matters for Investors [Yahoo! Finance]
4/16
08:03 am
orka
Oruka Therapeutics price target raised to $85 from $45 at Wedbush [Yahoo! Finance]
Low
Report
Oruka Therapeutics price target raised to $85 from $45 at Wedbush [Yahoo! Finance]
4/15
08:41 am
orka
Oruka Therapeutics (ORKA) had its price target raised by Wedbush from $45.00 to $85.00. They now have an "outperform" rating on the stock.
Medium
Report
Oruka Therapeutics (ORKA) had its price target raised by Wedbush from $45.00 to $85.00. They now have an "outperform" rating on the stock.
4/13
10:22 am
orka
Oruka Therapeutics (ORKA) had its "buy" rating reaffirmed by Guggenheim. They now have a $125.00 price target on the stock.
Low
Report
Oruka Therapeutics (ORKA) had its "buy" rating reaffirmed by Guggenheim. They now have a $125.00 price target on the stock.
4/13
08:00 am
orka
Oruka Therapeutics (ORKA) had its price target raised by BTIG Research from $73.00 to $78.00. They now have a "buy" rating on the stock.
Low
Report
Oruka Therapeutics (ORKA) had its price target raised by BTIG Research from $73.00 to $78.00. They now have a "buy" rating on the stock.
4/13
08:00 am
orka
Oruka Therapeutics (ORKA) had its price target raised by HC Wainwright from $40.00 to $70.00. They now have a "buy" rating on the stock.
Low
Report
Oruka Therapeutics (ORKA) had its price target raised by HC Wainwright from $40.00 to $70.00. They now have a "buy" rating on the stock.
4/7
02:33 pm
orka
Oruka Therapeutics (ORKA) had its price target raised by Barclays PLC from $50.00 to $78.00. They now have an "overweight" rating on the stock.
Low
Report
Oruka Therapeutics (ORKA) had its price target raised by Barclays PLC from $50.00 to $78.00. They now have an "overweight" rating on the stock.
3/12/2026
04:05 pm
orka
oruka therapeutics, inc.
BEAT
Report
25.0%
oruka therapeutics, inc.
11/12/2025
04:05 pm
orka
oruka therapeutics, inc.
BEAT
Report
-5.8%
oruka therapeutics, inc.
8/11/2025
04:04 pm
orka
oruka therapeutics, inc.
BEAT
Report
0.7%
oruka therapeutics, inc.
4/21
04:23 pm
orka
Form 424B7 Oruka Therapeutics, Inc.
Low
Report
Form 424B7 Oruka Therapeutics, Inc.
4/17
04:21 pm
orka
Form ARS Oruka Therapeutics, Inc. For: Dec 31
Low
Report
Form ARS Oruka Therapeutics, Inc. For: Dec 31
4/17
04:15 pm
orka
Form DEFA14A Oruka Therapeutics, Inc.
Low
Report
Form DEFA14A Oruka Therapeutics, Inc.
4/17
04:10 pm
orka
Form DEF 14A Oruka Therapeutics, Inc. For: Jun 02
Low
Report
Form DEF 14A Oruka Therapeutics, Inc. For: Jun 02
4/15
06:46 pm
orka
Form 4 Oruka Therapeutics, Inc. For: Apr 15 Filed by: Goncalves Joana
Medium
Report
Form 4 Oruka Therapeutics, Inc. For: Apr 15 Filed by: Goncalves Joana
4/15
04:54 pm
orka
Form 144 Oruka Therapeutics, Inc. Filed by: Goncalves Joana
Medium
Report
Form 144 Oruka Therapeutics, Inc. Filed by: Goncalves Joana
4/13
06:03 am
orka
Form EFFECT Oruka Therapeutics, Inc.
Medium
Report
Form EFFECT Oruka Therapeutics, Inc.
4/2
04:07 pm
orka
Form S-3 Oruka Therapeutics, Inc.
Medium
Report
Form S-3 Oruka Therapeutics, Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register